News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Carl Ola Landgren: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patient’s access to new drugs
C. Ola Landgren/X
Apr 14, 2024, 12:56

Carl Ola Landgren: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patient’s access to new drugs

Carl Ola Landgren, Professor of Medicine, Chief of Myeloma Division at University of Miami, shared a post on X:

“I started the EVIDENCE meta-analysis in 2009. After 15 years of work, I will present 4/12 at ODAC: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patient’s access to new drugs?”

Procced to the video.
Source: Carl Ola Landgren/X

cancer Carl Ola Landgren EVIDENCE meta-analysis multiple myeloma Myeloma Myeloma MRD ODAC OncoDaily Oncology oncology drug advisory committe University of Miami
Special Coverage
Insight
May 2, 2025, 05:48
Analysis Highlights Multi-Organ Adverse Events from Cancer Immunotherapies - FDA
Blog
May 2, 2025, 05:17
Oguna Kasam: Cancer survival should not depend on geography
Blog
May 2, 2025, 04:28
Gender Matters: Creating Inclusive and Safer Workspaces - ACREOL Global
Blog
May 2, 2025, 03:47
AI is revolutionizing cancer care - CancerX
Insight
May 2, 2025, 02:54
Stewart O'Callaghan: Lived experience discussion on identity terms in the young adult cancer community
Oncolibrary
May 2, 2025, 01:01
Tumor Markers: What They Are, How They Help and Their Role in Cancer Care
Blog
May 1, 2025, 20:49
Jennifer Bires: Patients Carrying Private Fears They Were Too Overwhelmed to Share
Blog
May 1, 2025, 20:14
NCI Center for Global Health Highlights Challenges of Conducting Cancer Trials in LMICs
Blog
May 1, 2025, 19:53
CCI4EU: A European Initiative Supporting Cancer Research and Innovation - ESO
Blog
May 1, 2025, 19:21
Rima Torosyan: Grateful to be part of the Retinoblastoma Workshop at the POEM Group’s 4th Scientific Meeting
Blog
May 1, 2025, 19:08
Jasmine Kamboj: Fantastic conversations on AI in Oncology with trailblazers
Blog
May 1, 2025, 18:56
Hadieh Eslampanah is Participating in the 17th CCI and SIOP Asia Riyadh 2025 Conference as a Board Member